The diagnostic and prognostic role of circulating miR-141 expression in non-small-cell lung cancer patients

por Zhao, Yizhuo
Publicado en Int J Clin Exp Pathol (2018)

Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer

por Chen, Dongfang, Xu, Jianlin, Qiao, Rong, Zhao, Yizhuo, Chu, Tianqing, Han, Baohui, Zhong, Runbo
Publicado en J Oncol (2020)

G4-Tetra DNA Duplex Induce Lung Cancer Cell Apoptosis in A549 Cells

por Xu, Xiaobo, Zhao, YiZhuo, Lu, Hu, Fu, Cuiping, Li, Xiao, Jiang, Liyan, Li, Shanqun
Publicado en Nanoscale Res Lett (2016)

Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer

por Cui, Shaohua, Zhang, Wei, Xiong, Liwen, Pan, Feng, Niu, Yanjie, Chu, Tianqing, Wang, Huimin, Zhao, Yizhuo, Jiang, Liyan
Publicado en Oncotarget (2016)

Is there a progression‐free survival benefit of first‐line crizotinib versus standard chemotherapy and second‐line crizotinib in ALK‐positive advanced lung adenocarcinoma? A retros...

por Cui, Shaohua, Zhao, Yizhuo, Dong, Lili, Gu, Aiqin, Xiong, Liwen, Qian, Jialin, Zhang, Wei, Niu, Yanjie, Pan, Feng, Jiang, Liyan
Publicado en Cancer Med (2016)

Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors

por Cui, Shaohua, Xiong, Liwen, Lou, Yuqing, Shi, Huangping, Gu, Aiqin, Zhao, Yizhuo, Chu, Tianqing, Wang, Huimin, Zhang, Wei, Dong, Lili, Jiang, Liyan
Publicado en J Thorac Dis (2016)

Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases

por Qiao, Rong, Zhong, Runbo, Xu, Jianlin, Zhang, Yanwei, Zhang, Bo, Wang, Shuyuan, Lou, Yuqing, Chen, Dongfang, Chang, Qing, Zhao, Yizhuo, Han, Baohui
Publicado en J Cardiothorac Surg (2019)

ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer

por GAO, ZHIQIANG, HAN, BAOHUI, SHEN, JIE, GU, AIQIN, QI, DAJIANG, HUANG, JINSU, SHI, CHUNLEI, XIONG, LIWEN, ZHAO, YIZHUO, JIANG, LIYAN, WANG, HUIMIN, CHEN, YURONG
Publicado 2011

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients

por Xiong, Liwen, Cui, Shaohua, Ding, Jingyan, Sun, Yun, Zhang, Longfu, Zhao, Yizhuo, Gu, Aiqin, Chu, Tianqing, Wang, Huimin, Zhong, Hua, Ye, Xin, Gu, Yi, Zhang, Xin, Hu, Min, Jiang, Liyan
Publicado en Oncotarget (2017)

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

por Han, Baohui, Li, Kai, Zhao, Yizhuo, Li, Baolan, Cheng, Ying, Zhou, Jianying, Lu, You, Shi, Yuankai, Wang, Zhehai, Jiang, Liyan, Luo, Yi, Zhang, Yiping, Huang, Cheng, Li, Qiang, Wu, Guoming
Publicado en Br J Cancer (2018)

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

por Wang, Jing, Zhao, Yizhuo, Wang, Qiming, Zhang, Li, Shi, Jianhua, Wang, Zhehai, Cheng, Ying, He, Jianxing, Shi, Yuankai, Yu, Hao, Zhao, Yang, Chen, Weiqiang, Luo, Yi, Wang, Xiuwen, Nan, Kejun, Jin, Faguang, Dong, Jian, Li, Baolan, Liu, Zhujun, Han, Baohui, Li, Kai
Publicado en Cancer Biol Med (2018)

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial...

por Han, Baohui, Li, Kai, Wang, Qiming, Zhang, Li, Shi, Jianhua, Wang, Zhehai, Cheng, Ying, He, Jianxing, Shi, Yuankai, Zhao, Yizhuo, Yu, Hao, Zhao, Yang, Chen, Weiqiang, Luo, Yi, Wu, Lin, Wang, Xiuwen, Pirker, Robert, Nan, Kejun, Jin, Faguang, Dong, Jian, Li, Baolan, Sun, Yan
Publicado en JAMA Oncol (2018)

Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer

por Lu, Jun, Zhong, Hua, Wu, Jun, Chu, Tianqing, Zhang, Lele, Li, Hua, Wang, Qiming, Li, Rong, Zhao, Yizhuo, Gu, Aiqin, Wang, Huimin, Shi, Chunlei, Xiong, Liwen, Zhang, Xueyan, Zhang, Wei, Lou, Yuqing, Yan, Bo, Dong, Yu, Zhang, Yanwei, Li, Baolan, Zhang, Li, Zhao, Xiaodong, Li, Kai, Han, Baohui
Publicado en Adv Sci (Weinh) (2019)

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

por Jiang, Liyan, Huang, Jiaqi, Higgs, Brandon W., Hu, Zhibin, Xiao, Zhan, Yao, Xin, Conley, Sarah, Zhong, Haihong, Liu, Zheng, Brohawn, Philip, Shen, Dong, Wu, Song, Ge, Xiaoxiao, Jiang, Yue, Zhao, Yizhuo, Lou, Yuqing, Morehouse, Chris, Zhu, Wei, Sebastian, Yinong, Czapiga, Meggan, Oganesyan, Vaheh, Fu, Haihua, Niu, Yanjie, Zhang, Wei, Streicher, Katie, Tice, David, Zhao, Heng, Zhu, Meng, Xu, Lin, Herbst, Ronald, Su, Xinying, Gu, Yi, Li, Shyoung, Huang, Lihua, Gu, Jianren, Han, Baohui, Jallal, Bahija, Shen, Hongbing, Yao, Yihong
Publicado en PLoS Genet (2016)